Follow
Farbod Fadai
Title
Cited by
Cited by
Year
Safety evaluation of saffron stigma (Crocus sativus L.) aqueous extract and crocin in patients with schizophrenia
B Mousavi, SZ Bathaie, F Fadai, Z Ashtari, S Farhang, S Hashempour, ...
Avicenna journal of phytomedicine 5 (5), 413, 2015
832015
Saffron aqueous extract prevents metabolic syndrome in patients with schizophrenia on olanzapine treatment: a randomized triple blind placebo controlled study
F Fadai, B Mousavi, Z Ashtari, S Farhang, S Hashempour, N Shahhamzei, ...
Pharmacopsychiatry 47 (04/05), 156-161, 2014
712014
Effects of demographic factors, body mass index, alcohol drinking and smoking habits on irritable bowel syndrome: a case control study
N Farzaneh, M Ghobaklou, B Moghimi‑Dehkordi, N Naderi, F Fadai
Annals of medical and health sciences research 3 (3), 391-396, 2013
482013
Association analysis of the dopamine transporter (DAT1)‐67A/T polymorphism in bipolar disorder
MR Keikhaee, F Fadai, MR Sargolzaee, A Javanbakht, H Najmabadi, ...
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 135 …, 2005
422005
Association of the dopamine transporter gene (DAT1) core promoter polymorphism −67T variant with schizophrenia
N Khodayari, M Garshasbi, F Fadai, A Rahimi, L Hafizi, A Ebrahimi, ...
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 129 …, 2004
412004
Evaluation of psychological aspects among subtypes of irritable bowel syndrome
N Farzaneh, M Ghobakhlou, B Moghimi-Dehkordi, N Naderi, F Fadai
Indian journal of psychological medicine 34 (2), 144-148, 2012
232012
A point mutation at the calreticulin gene core promoter conserved sequence in a case of schizophrenia
A Aghajani, A Rahimi, F Fadai, A Ebrahimi, H Najmabadi, M Ohadi
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 141 …, 2006
212006
Anxiety and depression in a sample of Iranian patients with irritable bowel syndrome
N Farzaneh, M Ghobakhlou, B Moghimi-Dehkordi, N Naderi, F Fadai
Iranian Journal of Psychiatry and Behavioral Sciences 7 (1), 30, 2013
192013
Self stigma among people with bipolar-I disorder in Iran
G Sadighi, MR Khodaei, F Fadaie, A Mirabzadeh, A Sadighi
Iranian Rehabilitation Journal 13 (1), 32-28, 2015
172015
Applying psychoeducational program on general health and communication skills in caregivers of patients with schizophrenia: A randomized controlled trial
O Rezaei, A Bayani, Y Mokhayeri, K Waye, Y Sadat, J Haroni, M Latifi, ...
The European Journal of Psychiatry 32 (4), 174-181, 2018
152018
Identifying Some Risk Factors of Time to Relapses in Schizophrenic Patients using Bayesian Approach with Event-Dependent Frailty Model
Maryam Rahmati, Mehdi Rahgozar, Farbod Fadaei, Enayatollah Bakhshi,Leila ...
iranian journal of psychiatry 10 (2), 123-127, 2015
152015
Psychological features in patients with and without irritable bowel syndrome: A case–control study using Symptom Checklist-90-Revised
F Farbod, N Farzaneh, MD Bijan, G Mehdi, N Nosratollah
Indian journal of psychiatry 57 (1), 68-72, 2015
152015
Ali beigi N, Farhang S, Hashempour S, et al. Saffron aqueous extract prevents metabolic syndrome in patients with schizophrenia on olanzapine treatment: A randomized triple …
F Fadai, B Mousavi, Z Ashtari
Pharmacopsychiatry 47 (4-5), 156-61, 2014
142014
Factors associated with HIV testing among people who inject drugs Tehran
M Noroozi, A Noroozi, A Farhoudian, F Mohammadi, P Higgs, A Rahmani, ...
Journal of Substance Use 23 (3), 322-326, 2018
112018
The effect of bupropion on sexual function in patients with Schizophrenia: A randomized clinical trial
O Rezaei, F Fadai, M Sayadnasiri, MA Palizvan, B Armoon, M Noroozi
The European Journal of Psychiatry 32 (1), 11-15, 2018
112018
Determining the best form factor formula for Loblolly Pine (Pinus taeda L.) plantations at the age of 18, in Guilan-northern Iran
F Fadaei, A Fallah, H Latifi, K Mohammadi
Caspian Journal of Environmental Sciences 6 (1), 19-24, 2008
102008
Application of recurrent events model in determining the risk factors of recurrence of Schizophrenia
R Mehdi, C Leila, B Enayatollah, K Masoud, F Farbod, B Akbar
92012
Injecting and sexual networks and sociodemographic factors and dual HIV risk among people who inject drugs: a cross-sectional study in Kermanshah Province, Iran
M Noroozi, A Mirzazadeh, A Noroozi, H Sharifi, P Higgs, ...
Addiction & health 8 (3), 186, 2016
82016
The effect of poetry therapy group on communicational skills of schizophrenic patient
M Qorbani, F Fadaei, H Rahmani Anaraki
Nursing And Midwifery Journal 13 (11), 919-927, 2016
82016
The therapeutic effectiveness of risperidone on negative symptoms of schizophrenia in comparison with haloperidol: a randomized clinical trial
A Mirabzadeh, P Kimiaghalam, F Fadai, M Samiei, R Daneshmand
Basic and Clinical Neuroscience 5 (3), 212, 2014
82014
The system can't perform the operation now. Try again later.
Articles 1–20